STOCK TITAN

Precigen (PGEN) CEO receives large RSU and stock option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRECIGEN, INC. reported that President and CEO Helen Sabzevari received new equity awards. She was granted 410,000 Restricted Stock Units, each representing one share of common stock, and options on 1,366,000 shares of common stock at an exercise price of $4.11 per share.

The options vest 25% on May 23, 2027 and then in equal monthly installments over three years, while the RSUs vest 25% on the same date and then in equal six‑month installments over three years. No shares were sold in these transactions.

Positive

  • None.

Negative

  • None.
Insider Sabzevari Helen
Role President and CEO
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock (Right to Buy) 1,366,000 $0.00 --
Grant/Award Restricted Stock Units 410,000 $0.00 --
Holdings After Transaction: Option to Purchase Common Stock (Right to Buy) — 1,366,000 shares (Direct, null); Restricted Stock Units — 410,000 shares (Direct, null)
Footnotes (1)
  1. The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter.
RSU grant size 410,000 units Restricted Stock Units granted to CEO on April 20, 2026
Option grant size 1,366,000 options Options to purchase common stock granted on April 20, 2026
Option exercise price <money>$4.11</money> per share Conversion or exercise price for new stock options
Option expiration April 20, 2036 Expiration date for the granted stock options
RSUs underlying shares 410,000 shares Each RSU represents one share of Precigen common stock
Options underlying shares 1,366,000 shares Each option relates to one share of common stock
Restricted Stock Units financial
"security_title: "Restricted Stock Units" and footnote defining each RSU"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Option to Purchase Common Stock (Right to Buy) financial
"security_title: "Option to Purchase Common Stock (Right to Buy)""
vest financial
"The options vest 25% on May 23, 2027 and in equal monthly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
""expiration_date": "2036-04-20T00:00:00.000Z" for the stock options"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
contingent right financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sabzevari Helen

(Last)(First)(Middle)
20374 SENECA MEADOWS PARKWAY

(Street)
GERMANTOWN MARYLAND 20876

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock (Right to Buy)$4.1104/20/2026A1,366,000 (1)04/20/2036Common Stock1,366,000$01,366,000D
Restricted Stock Units(2)04/20/2026A410,000 (3) (3)Common Stock410,000$0410,000D
Explanation of Responses:
1. The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
3. The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter.
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact04/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Precigen (PGEN) CEO Helen Sabzevari receive?

Helen Sabzevari received 410,000 Restricted Stock Units and options on 1,366,000 shares of Precigen common stock. These grants are compensation awards, not market purchases, and were reported as acquisitions on the Form 4 insider filing.

What is the exercise price of Helen Sabzevari’s new Precigen stock options?

The new options granted to Helen Sabzevari have an exercise price of $4.11 per share. This means she can buy Precigen common stock at $4.11 once the options vest, if she chooses to exercise them in the future.

How do the new Precigen RSUs granted to the CEO vest over time?

The 410,000 RSUs granted to the CEO vest 25% on May 23, 2027, then in equal six‑month installments for three years. This multi‑year vesting schedule encourages longer‑term alignment between executive compensation and shareholder interests.

What is the vesting schedule for Helen Sabzevari’s new Precigen stock options?

The granted options vest 25% on May 23, 2027, then in equal monthly installments over the following three years. This gradual vesting structure ties the CEO’s potential option value to continued service with Precigen.

Did Helen Sabzevari buy or sell any Precigen (PGEN) shares in this Form 4?

No open‑market buys or sells occurred in this Form 4. The filing reports grant or award acquisitions of RSUs and stock options as compensation, with no corresponding sales or exercises that would change market float.

How many underlying Precigen common shares are covered by the CEO’s new awards?

The new grants cover 410,000 underlying shares through RSUs and 1,366,000 underlying shares through options. Each RSU or option is linked to one share of Precigen common stock according to the Form 4 disclosure.